ArticleJournal of hepatocellular carcinoma2026
SR-HCC Score: A Novel Nomogram for Predicting Spontaneous Rupture in Hepatocellular Carcinoma Patients.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hepatocellular carcinoma (HCC) Spontaneous rupture (srHCC) is a life-threatening complication with a high mortality rate; however, no integrated predictive tool exists. This study aimed to develop and validate a novel nomogram (SR-HCC score) for srHCC risk prediction using a combination of clinical, radiological, and laboratory parameters. Methods: This retrospective cohort study included 186 HCC patients from The Third People's Hospital of Kunming (2010-2025), randomly split into training (80%) and validation (20%) sets. Covariates included demographic, tumor-related, and laboratory indices. Univariate and multivariate logistic regression analyses were used to identify independent predictors that were integrated into the nomogram. Model performance was evaluated using Receiver Operating Characteristic (ROC) curves (discrimination) and calibration curves. Results: Key independent predictors of srHCC included tumor diameter (3-5 cm and 5-10 cm), number of tumors (2-3), capsular protrusion, Alpha-Fetoprotein (AFP) ≥100 ng/mL, moderate ΔALT (0-200 U/L, inverse association), and ΔAST >200 U/L. The nomogram achieved excellent discrimination (Area Under the Curve, AUC = 0.9617 in the training set; 0.9630 in the validation set) and good calibration, with predicted probabilities that closely matched the observed outcomes. Conclusion: SR-HCC score is a reliable and user-friendly tool for individualized srHCC risk stratification. This enables clinicians to prioritize preventive interventions and optimize surveillance, especially in resource-limited settings, ultimately improving patient outcomes by preventing catastrophic ruptures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.